dr. bhave on promising anti-her2 agents in her2 breast cancer
Published 4 years ago • 181 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:25
dr. bhave discusses [fam-] trastuzumab deruxtecan in her2 breast cancer
-
2:03
dr. pegram on promising novel agents in her2 metastatic breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:50
dr lynce on ongoing trials evaluating novel combinations in inflammatory breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
1:55
dr. hurvitz on novel emerging agents in her2 breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:24
dr. yardley on emerging agents in her2-positive breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
0:52
dr. o'regan on impact of targeted agents in her2 breast cancer
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
1:05
dr. hamilton on the evolution of treatment in her2 breast cancer
-
1:51
dr. kolberg on cost-effectiveness of pertuzumab in her2-positive breast cancer
-
1:54
dr. murthy on her2climb trial results in her2 breast cancer